Previous research overstated the generalizability of the Exenatide Study of Cardiovascular Event Lowering trial results by omitting the restriction on the percentage of patients without a prior cardiovascular event.
Maureen J. Lage, PhD
Advertisement
Articles by Maureen J. Lage, PhD
Adherence to glucose-lowering agents was associated with a significant reduction in use of acute care resources without any increased total medical costs.
The analysis examines the annual economic effect of medically treating patients with prostate cancer and subsequent bone metastases.
Advertisement
Latest Updated Articles
- The Cost of Treating Skeletal-Related Events in Patients With Prostate Cancer
Published: May 15th 2008 | Updated:
- Medication Adherence and Improved Outcomes Among Patients With Type 2 Diabetes
Published: July 31st 2017 | Updated:
- A Comparison of Abciximab Use in MCO and Non-MCO Populations
Published: January 1st 2001 | Updated:
- Comment on Generalizability of GLP-1 RA CVOTs in US T2D Population
Published: April 8th 2019 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Prescription Access Crisis: 40% of GLP-1 RA Rx Are Unfilled
2
Value-Based Care Offers Solutions to Patient Access Challenges: Brian Mulherin, MD
3
New WHO Reports Sounds Alarm on Antimicrobial Resistance
4
FDA Expands Upadacitinib Label for Treating Inflammatory Bowel Disease
5
